{
  "id": 1769683087169,
  "seqId": 177,
  "title": "Stargardt Disease & Fundus Flavimaculatus: A Clinical Compendium",
  "summary": "Stargardt disease and fundus flavimaculatus are the most common inherited macular dystrophies in both adults and children, characterized by central vision loss and unique retinal flecks. This guide details the genetics, imaging findings, and emerging treatments for these progressive conditions.",
  "date": "2026-01-29T10:38:07.169Z",
  "data": {
    "title": "Stargardt Disease & Fundus Flavimaculatus: A Clinical Compendium",
    "summary": "Stargardt disease and fundus flavimaculatus are the most common inherited macular dystrophies in both adults and children, characterized by central vision loss and unique retinal flecks. This guide details the genetics, imaging findings, and emerging treatments for these progressive conditions.",
    "summary_illustration": "<svg viewBox='0 0 100 100' xmlns='http://www.w3.org/2000/svg'><circle cx='50' cy='50' r='45' fill='none' stroke='#1E3A8A' stroke-width='2'/><circle cx='50' cy='50' r='12' fill='#B45309'/><path d='M30,30 L32,32 M70,30 L68,32 M30,70 L32,68 M70,70 L68,68 M50,25 L50,28 M50,75 L50,72 M25,50 L28,50 M75,50 L72,50' stroke='#F59E0B' stroke-width='3' stroke-linecap='round'/><path d='M40,40 Q50,45 60,40' stroke='#1E3A8A' fill='none'/></svg>",
    "sections": [
      {
        "title": "Core Disease Fundamentals",
        "icon": "visibility",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "center": "Stargardt / FFM",
          "branches": [
            "Variants of the same disease",
            "Most common macular dystrophy in adults and children",
            "Common cause of central visual loss in adults < 50 years",
            "Prevalence: 1 in 8000–10 000 people"
          ]
        }
      },
      {
        "title": "Genetic Classification & Types",
        "icon": "dna",
        "type": "table",
        "layout": "full_width",
        "color_theme": "purple",
        "content": {
          "headers": [
            "Type",
            "Inheritance",
            "Gene",
            "Mechanism / Location"
          ],
          "rows": [
            [
              "STGD1",
              "AR (Autosomal Recessive)",
              "ABCA4",
              "Chromosome 1p; affects recycling of 11-cis-retinal"
            ],
            [
              "STGD3",
              "AD (Autosomal Dominant)",
              "ELOVL4",
              "Primary genetic driver for Type 3"
            ],
            [
              "STGD4",
              "AD (Autosomal Dominant)",
              "PROM1",
              "Primary genetic driver for Type 4"
            ]
          ]
        }
      },
      {
        "title": "Clinical Presentation & Prognosis",
        "icon": "history_edu",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": [
          "Presentation: Typically in childhood or adolescence, but sometimes later.",
          "Prognosis: Poor.",
          "Visual Acuity: Once below 6/12, it tends to worsen rapidly."
        ]
      },
      {
        "title": "Symptom Profile",
        "icon": "patient_list",
        "type": "plain_text",
        "layout": "half_width",
        "color_theme": "blue",
        "content": "Symptoms: Gradual impairment of central vision occurs that may be out of proportion to examination findings and manifests with difficulty when reading. A quarter of childhood-onset STGDT1 do not have any retinal lesions at presentation and malingering may be suspected, but OCT imaging soon clarifies this misconception."
      },
      {
        "title": "Macular Signs & Evolution",
        "icon": "biometrics",
        "type": "process",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Initial Stage: Normal or non-specific mottling and fine flecks.",
          "Intermediate Stage: Progressing to an oval ‘snail slime’ or ‘beaten-bronze’ appearance.",
          "Late Stage: Progressing to atrophy that may tend to a bull’s-eye configuration.",
          "Rare Complication: Macular neovascularization (MNV) develops in a small number of patients."
        ]
      },
      {
        "title": "Retinal Fleck Characteristics",
        "icon": "texture",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": [
          "Description: Numerous yellow–white round, oval or pisciform (fish-shaped) lesions.",
          "Location: At the level of the RPE.",
          "Distribution: Confined to the posterior pole or extending to the mid-periphery.",
          "Dynamics: New lesions develop as older ones become ill-defined and atrophic.",
          "Sparing: Structure and function of the parapapillary retina is spared (except in late-stage severe disease)."
        ]
      },
      {
        "title": "Visualizing Retinal Progression (Fig 15.18)",
        "icon": "image",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "blue",
        "content": [
          "(A) Non-specific macular mottling",
          "(B) ‘snail slime’ maculopathy surrounded by flecks",
          "(C) Quasi bull’s-eye maculopathy surrounded by flecks – note the ‘beaten-bronze’ paramacular appearance",
          "(D) Geographic atrophy",
          "(E) Posterior pole flecks",
          "(F) Posterior pole flecks extending to the mid-periphery"
        ]
      },
      {
        "title": "Diagnostic Investigation Suite",
        "icon": "query_stats",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "purple",
        "content": [
          "Visual Fields: Show central loss; microperimetry can accurately document progression.",
          "FA (Fluorescein Angiography): Classic 'dark choroid' (masking of background fluorescence by lipofuscin). Mixed hyper/hypofluorescence. Fresh flecks show early hypo (blockage) and late hyper (staining). Old flecks show RPE window defects.",
          "ICGA (Indocyanine Green Angiography): Hypofluorescent spots, often more numerous than seen clinically.",
          "FAF (Fundus Autofluorescence): Key to early diagnosis. Hyperautofluorescent flecks and macular hypoautofluorescence.",
          "OCT (Optical Coherence Tomography): Demonstrates outer retinal atrophy.",
          "ERG (Electroretinogram): Photopic is normal to subnormal; scotopic may be normal.",
          "EOG (Electro-oculogram): Commonly subnormal, especially in advanced cases."
        ]
      },
      {
        "title": "Imaging Insights (Fig 15.19)",
        "icon": "photo_library",
        "type": "plain_text",
        "layout": "full_width",
        "color_theme": "blue",
        "content": "(A) Central visual field loss; (B) FA showing hyperfluorescent flecks; (C) FAF in early onset disease showing macular hypoautofluorescent and surrounding hyperautofluorescent flecks. The black areas in the macula represent RPE atrophy; (D) OCT of (C) showing RPE and outer retinal atrophy with relative sparing of the fovea (arrow). Increased backscatter from the choroid indicates atrophic changes of the RPE; (E) FAF showing hyperfluorescent flecks in late disease; (F) OCT of (E) showing significant outer retinal thinning notably in the foveola (arrow). Adjacent ellipsoid zone shows altered reflectivity."
      },
      {
        "title": "Critical Contraindication",
        "icon": "warning",
        "type": "red_flag",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Avoid vitamin A supplementation as it may accelerate lipofuscin accumulation."
        ]
      },
      {
        "title": "Management & Clinical Trials",
        "icon": "medical_services",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "General measures: Consider as for RP (Retinitis Pigmentosa).",
          "Light: Protection from excessive high-energy light exposure may be particularly important.",
          "Trial (a): Gene therapy using a lentiviral vector for ABCA4.",
          "Trial (b): Stem cell therapy.",
          "Trial (c): Pharmatherapy to reduce lipofuscin accumulation.",
          "Trial (d): Metformin taken by mouth."
        ]
      },
      {
        "title": "Clinical Pearl",
        "icon": "lightbulb",
        "type": "remember",
        "layout": "full_width",
        "color_theme": "yellow",
        "content": {
          "mnemonic": "ABCA4",
          "explanation": "Stargardt disease is the most commonly inherited macular dystrophy and is usually associated with mutations in the ABCA4 gene."
        }
      }
    ],
    "chapterId": "uncategorized"
  },
  "chapterId": "vitreoretinal",
  "_newlyImported": 1769683087169,
  "communityId": "sub_1769672499124_v2cjvzyfo",
  "communityAuthor": "Dodiii",
  "communityDate": "2026-01-29T07:41:39.125Z",
  "_chapterUpdated": 1769969368003,
  "_serverSynced": true
}